ENTITY

Cellivery Therapeutics (268600 KS)

Analysis

Health Care • South Korea

Cellivery Therapeutics, Inc. operates as a pharmaceutical company. The Company develops and sells proteins drugs and other products, as well as conducts research and development activities. Cellivery Therapeutics markets its products throughout Korea.

Refresh

No events found

We’ll display events we find for Cellivery Therapeutics here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00